Analysts’ Viewpoint
Increase in non-invasive cosmetic procedures, rise in disposable income, and changing consumer preferences are driving the global facial injectables market. Growing number of individuals are opting for facial injectables to address aesthetic concerns. Hence, demand for dermal fillers and botulinum toxin treatments has increased as people seek to enhance their appearance and combat signs of aging. Aging population and the desire to maintain youthful look are anticipated to bolster market expansion. Furthermore, surge in accessibility and affordability of these treatments, particularly in emerging economies, are likely to propel the global facial injectables market size.
Advancements in technology and product innovation offer lucrative opportunities to market players. Manufacturers are introducing improved facial injectables with enhanced efficacy, safety, and longer lasting effects in order to increase consumer base.
Facial injectables encompass dermal fillers and botulinum toxin, which are used to enhance appearance and address aesthetic concerns. Dermal fillers are gel-like substances injected to restore volume, smoothen wrinkles, and improve facial contours.
These are commonly applied to areas such as cheeks, lips, and nasolabial folds. Botulinum toxin, known as Botox, is injected into facial muscles to temporarily relax them, reducing dynamic wrinkles caused by muscle movements. This treatment is effective for frown lines, forehead wrinkles, and crow's feet.
Facial injectables provide a non-invasive solution for achieving a more youthful and rejuvenated look. Dermal fillers typically contain hyaluronic acid, calcium hydroxylapatite, or poly-L-lactic acid, while Botox is a neurotoxic protein. These treatments are performed by qualified professionals and offer temporary results, usually lasting several months to a year.
Surge in aesthetic consciousness among individuals leading to increased demand for cosmetic procedures is bolstering the global facial injectables market development. The number of people seeking aesthetic enhancements and cosmetic treatments has increased in the past few years. This can be ascribed to factors such as social media influence, changing beauty standards, and desire for self-improvement.
Introduction of cost-effective facial injectables is also fueling market growth. Advancements in technology have allowed for the development of more affordable injectable products without compromising on quality or efficacy. This has made facial injectables more accessible to a broader consumer base, including those who may have been previously deterred by high costs.
According to the International Society of Aesthetic Plastic Surgery (ISAPS) report in 2021, over 10,129,528 cosmetic surgical procedures were performed in 2021, with non-surgical procedures, such as facial injectables, accounting for a significant number. Popular injectables mentioned in the report include calcium hydroxylapatite, poly-L-lactic acid, botulinum toxin, and hyaluronic acid. This data underscores the widespread adoption of facial injectables and their positive impact on the market's growth.
Increase in demand for non-invasive procedures is a significant driver of global facial injectables market demand. Consumers are increasingly opting for cosmetic treatments that provide aesthetic enhancements without the need for invasive surgery. This shift in preference is driven by several factors, including a desire for quicker recovery, minimal downtime, and reduced risks associated with surgical procedures.
Minimally invasive surgeries are rapidly replacing invasive surgeries in the field of aesthetics. Patients are increasingly seeking procedures that offer similar benefits to traditional surgeries but with less invasiveness and associated complications.
The American Society of Plastic Surgeons reported that nearly 18 million aesthetic treatments were performed in the U.S. in 2020. Of these, around 16 million were non-invasive or minimally invasive procedures, highlighting the overwhelming demand for such treatments among patients. This data underscores the increasing adoption of minimally invasive surgeries and the role of facial injectables in meeting this demand.
Adoption of non-invasive procedures is also driven by societal factors. There is a general trend toward seeking natural-looking results and subtle enhancements, which can be achieved effectively through facial injectables. Patients are increasingly prioritizing procedures that maintain their facial expressions and allow for a gradual transformation, rather than drastic changes associated with surgical interventions.
In terms of product type, the hyaluronic acid (HA) segment accounted for the largest global facial injectables market share in 2022. Hyaluronic acid is a naturally occurring substance found in the human body and is widely used in the cosmetic industry for facial rejuvenation and volumizing.
Hyaluronic acid-based dermal fillers are popular due to the ability to add volume, smoothen wrinkles, and enhance facial contours. These are commonly used for procedures such as lip augmentation, cheek augmentation, and filling of nasolabial folds.
Demand for hyaluronic acid-based dermal fillers has been consistently high, driven by factors such as increase in geriatric population, rise in consumer focus on appearance, and advancements in aesthetic procedures.
Based on application, the facial line correction segment is likely to dominate the global facial injectables industry during the forecast period. Facial line correction refers to the treatment of wrinkles and fine lines on the face using injectable fillers, primarily hyaluronic acid-based dermal fillers.
The facial line correction segment's dominance can be ascribed to rise in demand for non-surgical cosmetic procedures aimed at reducing visible signs of aging. As individuals seek to maintain a youthful appearance without undergoing invasive surgical procedures, facial line correction with injectable fillers has become an attractive option.
Facial line correction treatment can address a range of concerns, including the treatment of crow's feet, forehead lines, frown lines, and marionette lines. This versatility makes it a popular choice among both younger individuals seeking preventive measures and older individuals looking to reverse the signs of aging.
In terms of end-user, the hospitals segment is projected to account for leading share of the global facial injectables market during the forecast period.
Hospitals are equipped with advanced medical infrastructure and facilities, allowing them to provide comprehensive and specialized care. These have the necessary resources to perform various cosmetic procedures, including facial injectables, in a safe and controlled environment.
Hospitals typically employ a skilled and diverse medical workforce, including plastic surgeons, dermatologists, and aesthetic specialists. These professionals have the expertise and experience required to administer injectable treatments accurately and ensure optimal patient outcomes.
Hospitals often have access to a range of injectable products, including hyaluronic acid-based fillers, due to their established relationships with pharmaceutical manufacturers and suppliers. This enables hospitals to offer a diverse selection of products to meet the specific needs and preferences of their patients.
As per facial injectables market trends, North America accounted for leading market share in 2022. This is ascribed to large population seeking aesthetic enhancements, strong emphasis on youthful appearances, and high disposable income among consumers.
Advancements in injectable techniques, product formulations, and safety measures have contributed to market expansion in North America. The region has a well-established healthcare infrastructure, with a significant presence of specialized clinics, medical spas, and cosmetic surgery centers offering facial injectable treatments.
The market in North America is highly competitive, with leading manufacturers and pharmaceutical companies introducing innovative products to cater to the growing demand.
The facial injectables market in Asia Pacific is experiencing rapid growth driven by factors such as large population, increase in disposable income, growing beauty consciousness, and rise in demand for non-surgical cosmetic procedures. The market in the region is characterized by expanding aesthetic clinics, advancements in technology, and strong presence of key market players.
Expansion of product portfolio and mergers & acquisitions are key strategies adopted by prominent manufacturers in the market. Allergan, Inc., Ipsen (Mayroy SA), Merz Pharma, Suneva Medical, Inc., Medytox, Inc., Sinclair Pharma, Bloomage BioTechnology, Anika Therapeutics, Inc., Prollenium Medical Technologies, and Galderma are the prominent players in the market.
The facial injectables market report profiles key players based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
|
Size in 2022 |
US 13.5 Bn |
|
Forecast (Value) in 2031 |
More than US$ 37.1 Bn |
|
Growth Rate (CAGR) |
12.0% |
|
Forecast Period |
2023-2031 |
|
Historical Data Available for |
2017-2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
It was valued at US$ 13.5 Bn in 2022.
It is projected to reach more than US$ 37.1 Bn by 2031.
It is anticipated to advance at a CAGR of 12.0% from 2023 to 2031.
Rise in aesthetic consciousness, surge in number of cosmetic procedures, and increase in preference for minimally invasive treatments.
Hyaluronic acid (HA) was the leading segment, with more than 42% share in 2022.
North America is expected to account for the largest share from 2023 to 2031.
Allergan, Inc., Ipsen (Mayroy SA), Merz Pharma, Suneva Medical, Inc., Medytox, Inc., Sinclair Pharma, Bloomage BioTechnology, Anika Therapeutics, Inc., Prollenium Medical Technologies and Galderma.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Facial Injectables Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Facial Injectables Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Forces Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Pricing Analysis
5.3. Key Mergers & Acquisitions
5.4. Top 3 Players Operating in the Market Space
5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Facial Injectables Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017-2031
6.3.1. Collagen
6.3.2. Hyaluronic Acid (HA)
6.3.3. Botulinum Toxin Type A
6.3.4. Calcium Hydroxylapatite (CaHA)
6.3.5. Polymethylmethacrylate Beads (PMMA Microspheres)
6.3.6. Poly-L-Lactic Acid (PLLA)
6.3.7. Others (Polyalkylimide )
6.4. Market Attractiveness Analysis, by Product Type
7. Global Facial Injectables Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Facial Line Correction
7.3.2. Lip Augmentation
7.3.3. Acne Scar Treatment
7.3.4. Face Lift
7.3.5. Lipoatrophy Treatment
7.3.6. Others (earlobe rejuvenation)
7.4. Market Attractiveness Analysis, by Application
8. Global Facial Injectables Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Dermatology Clinics
8.3.3. Others (beauty clinics)
8.4. Market Attractiveness Analysis, by End-user
9. Global Facial Injectables Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Facial Injectables Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017-2031
10.2.1. Collagen
10.2.2. Hyaluronic Acid (HA)
10.2.3. Botulinum Toxin Type A
10.2.4. Calcium Hydroxylapatite (CaHA)
10.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
10.2.6. Poly-L-Lactic Acid (PLLA)
10.2.7. Others (Polyalkylimide)
10.3. Market Value Forecast, by Application, 2017-2031
10.3.1. Facial Line Correction
10.3.2. Lip Augmentation
10.3.3. Acne Scar Treatment
10.3.4. Face Lift
10.3.5. Lipoatrophy Treatment
10.3.6. Others (earlobe rejuvenation)
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Dermatology Clinics
10.4.3. Others (Beauty Clinics)
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Facial Injectables Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2031
11.2.1. Collagen
11.2.2. Hyaluronic Acid (HA)
11.2.3. Botulinum Toxin Type A
11.2.4. Calcium Hydroxylapatite (CaHA)
11.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
11.2.6. Poly-L-Lactic Acid (PLLA)
11.2.7. Others (Polyalkylimide)
11.3. Market Value Forecast, by Application, 2017-2031
11.3.1. Facial Line Correction
11.3.2. Lip Augmentation
11.3.3. Acne Scar Treatment
11.3.4. Face Lift
11.3.5. Lipoatrophy Treatment
11.3.6. Others (earlobe rejuvenation)
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Dermatology Clinics
11.4.3. Others (beauty clinics)
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Facial Injectables Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2031
12.2.1. Collagen
12.2.2. Hyaluronic Acid (HA)
12.2.3. Botulinum Toxin Type A
12.2.4. Calcium Hydroxylapatite (CaHA)
12.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
12.2.6. Poly-L-Lactic Acid (PLLA)
12.2.7. Others (Polyalkylimide)
12.3. Market Value Forecast, by Application, 2017-2031
12.3.1. Facial Line Correction
12.3.2. Lip Augmentation
12.3.3. Acne Scar Treatment
12.3.4. Face Lift
12.3.5. Lipoatrophy Treatment
12.3.6. Others (earlobe rejuvenation)
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Dermatology Clinics
12.4.3. Others (beauty clinics)
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Facial Injectables Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2031
13.2.1. Collagen
13.2.2. Hyaluronic Acid (HA)
13.2.3. Botulinum Toxin Type A
13.2.4. Calcium Hydroxylapatite (CaHA)
13.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
13.2.6. Poly-L-Lactic Acid (PLLA)
13.2.7. Others (Polyalkylimide)
13.3. Market Value Forecast, by Application, 2017-2031
13.3.1. Facial Line Correction
13.3.2. Lip Augmentation
13.3.3. Acne Scar Treatment
13.3.4. Face Lift
13.3.5. Lipoatrophy Treatment
13.3.6. Others (earlobe rejuvenation)
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Dermatology Clinics
13.4.3. Others (beauty clinics)
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Facial Injectables Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017-2031
14.2.1. Collagen
14.2.2. Hyaluronic Acid (HA)
14.2.3. Botulinum Toxin Type A
14.2.4. Calcium Hydroxylapatite (CaHA)
14.2.5. Polymethylmethacrylate Beads (PMMA Microspheres)
14.2.6. Poly-L-Lactic Acid (PLLA)
14.2.7. Others (Polyalkylimide)
14.3. Market Value Forecast, by Application, 2017-2031
14.3.1. Facial Line Correction
14.3.2. Lip Augmentation
14.3.3. Acne Scar Treatment
14.3.4. Face Lift
14.3.5. Lipoatrophy Treatment
14.3.6. Others (earlobe rejuvenation)
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Dermatology Clinics
14.4.3. Others (beauty clinics)
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2021)
15.3. Company Profiles
15.3.1. Allergan, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Ipsen (Mayroy SA)
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Merz Pharma
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Suneva Medical, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Medytox Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Sinclair Pharma
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Bloomage BioTechnology
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Anika Therapeutics, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Prollenium Medical Technologies
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.10. Galderma
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 03: Global Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 04: Global Facial Injectables Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 05: North America Facial Injectables Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 06: North America Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 07: North America Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 08: North America Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 09: Europe Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 10: Europe Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 11: Europe Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 12: Europe Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 15: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 16: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 17: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 18: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 19: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 20: Latin America Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 23: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 24: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Facial Injectables Market Value Share, by Product Type, 2022
Figure 03: Global Facial Injectables Market Value Share, by Application, 2022
Figure 04: Global Facial Injectables Market Value Share, by End-user, 2022
Figure 05: Global Facial Injectables Market Value Share, by Region, 2022
Figure 06: Global Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 07: Global Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 08: Global Facial Injectables Market Revenue (US$ Mn), by Collagen, 2017-2031
Figure 09: Global Facial Injectables Market Revenue (US$ Mn), by Hyaluronic Acid (HA), 2017-2031
Figure 10: Global Facial Injectables Market Revenue (US$ Mn), by Botulinum Toxin Type A, 2017-2031
Figure 11: Global Facial Injectables Market Revenue (US$ Mn), by Calcium Hydroxylapatite (CaHA), 2017-2031
Figure 12: Global Facial Injectables Market Revenue (US$ Mn), by Polymethylmethacrylate Beads (PMMA Microspheres), 2017-2031
Figure 13: Global Facial Injectables Market Revenue (US$ Mn), by Poly-L-Lactic Acid (PLLA), 2017-2031
Figure 14: Global Facial Injectables Market Revenue (US$ Mn), by Others (Polyalkylimide), 2017-2031
Figure 15: Global Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031
Figure 16: Global Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
Figure 17: Global Facial Injectables Market Revenue (US$ Mn), by Facial Line Correction, 2017-2031
Figure 18: Global Facial Injectables Market Revenue (US$ Mn), by Lip Augmentation, 2017-2031
Figure 19: Global Facial Injectables Market Revenue (US$ Mn), by Acne Scar Treatment, 2017-2031
Figure 20: Global Facial Injectables Market Revenue (US$ Mn), by Face Lift, 2017-2031
Figure 21: Global Facial Injectables Market Revenue (US$ Mn), by Lipoatrophy Treatment, 2017-2031
Figure 22: Global Facial Injectables Market Revenue (US$ Mn), by Others (earlobe rejuvenation), 2017-2031
Figure 23: Global Facial Injectables Market Value Share Analysis, by End-user, 2017-2031
Figure 24: Global Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
Figure 25: Global Facial Injectables Market Revenue (US$ Mn), by Hospitals, 2017-2031
Figure 26: Global Facial Injectables Market Revenue (US$ Mn), by Dermatology Clinics, 2017-2031
Figure 27: Global Facial Injectables Market Revenue (US$ Mn), by Others (beauty clinics), 2017-2031
Figure 28: Global Facial Injectables Market Value Share Analysis, by Region, 2022 and 2031
Figure 29: Global Facial Injectables Market Attractiveness Analysis, by Region, 2023-2031
Figure 30: North America Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
Figure 31: North America Facial Injectables Market Value Share Analysis, by Country, 2022 and 2031
Figure 32: North America Facial Injectables Market Attractiveness Analysis, by Country, 2023-2031
Figure 33: North America Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 34: North America Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 35: North America Facial Injectables Market Value Share Analysis (US$ Mn), by Application, 2017-2031
Figure 36: North America Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
Figure 37: North America Facial Injectables Market Value Share Analysis, by End-user, 2022 and 2031
Figure 38: North America Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
Figure 39: Europe Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
Figure 40: Europe Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 41: Europe Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 42: Europe Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 43: Europe Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 44: Europe Facial Injectables Market Value Share Analysis, by Application, 2017-2031
Figure 45: Europe Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
Figure 46: Europe Facial Injectables Market Value Share Analysis, by End-user, 2022 and 2031
Figure 47: Europe Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
Figure 48: Asia Pacific Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
Figure 49: Asia Pacific Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 50: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 51: Asia Pacific Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 52: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 53: Asia Pacific Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031
Figure 54: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
Figure 55: Asia Pacific Facial Injectables Market Value Share Analysis, by End-user, 2017-2031
Figure 56: Asia Pacific Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
Figure 57: Latin America Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
Figure 58: Latin America Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 59: Latin America Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 60: Latin America Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 61: Latin America Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 62: Latin America Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031
Figure 63: Latin America Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
Figure 64: Latin America Facial Injectables Market Value Share Analysis, by End-user, 2017-2031
Figure 65: Latin America Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
Figure 66: Middle East & Africa Facial Injectables Market Value (US$ Mn) Forecast, 2017-2031
Figure 67: Middle East & Africa Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 68: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 69: Middle East & Africa Facial Injectables Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 70: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 71: Middle East & Africa Facial Injectables Market Value Share Analysis, by Application, 2022 and 2031
Figure 72: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Application, 2023-2031
Figure 73: Middle East & Africa Facial Injectables Market Value Share Analysis, by End-user, 2017-2031
Figure 74: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by End-user, 2023-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Facial Injectables Market
